Status:
COMPLETED
A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis
Lead Sponsor:
Allergan
Conditions:
Conjunctivitis, Allergic
Eligibility:
All Genders
10+ years
Phase:
PHASE4
Brief Summary
This study will evaluate the duration of action of LASTACAFT® and Pataday™ as compared to artificial tears (placebo) in the prevention of ocular itching associated with allergic conjunctivitis.
Eligibility Criteria
Inclusion
- History of eye allergies within the past 24 months
- Willing to not wear contact lenses at least 72 hours prior to the study start and during the study period
Exclusion
- Current eye infection
- Eye surgery within 3 months or vision correction surgery within 6 months
- Any planned surgery during the study or 30 days after the study
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT01470118
Start Date
October 1 2011
End Date
December 1 2011
Last Update
February 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philadelphia, Pennsylvania, United States